MERCK&CO

Company Introduction: Merck & Co. (MSD) Singapore

Merck & Co., known as MSD outside the United States and Canada, is a global healthcare leader that has been inventing for life for over a century, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through its prescription medicines, vaccines, biologic therapies, and animal health products, MSD works with customers and operates in more than 140 countries to deliver innovative health solutions.

In Singapore, MSD maintains a significant and multifaceted presence. It operates as both a manufacturing entity (factory) and a commercial/trading operation.

Manufacturing Facilities (Factory):

MSD has a substantial manufacturing footprint in Singapore, specifically in the Tuas Biomedical Park. This site is a critical part of their global supply chain, responsible for the production of active pharmaceutical ingredients (APIs) and finished drug products. These advanced facilities utilize cutting-edge technology to ensure high-quality and efficient production of life-saving medicines and vaccines for global distribution.

Commercial and Trading Operations:

Beyond manufacturing, MSD Singapore also serves as a key commercial hub for the region. Its offices manage sales, marketing, distribution, and other business functions across Southeast Asia, ensuring that their innovative products reach patients and healthcare providers in various markets. This aspect of their operations involves the trading and distribution of their pharmaceutical and vaccine portfolios.

In summary, Merck & Co. (MSD) in Singapore is a comprehensive operation encompassing both advanced manufacturing facilities (factory) and robust commercial and trading functions.

Merck & Co., known as MSD outside North America, sells a wide range of pharmaceutical products and vaccines in Singapore across various therapeutic areas. These products include:

Oncology:

Keytruda (pembrolizumab)

Lynparza (olaparib) - co-developed with AstraZeneca

Lenvima (lenvatinib) - co-developed with Eisai

Vaccines:

Gardasil 9 (Human Papillomavirus 9-valent Vaccine)

Varivax (Varicella Virus Vaccine Live)

Pneumovax 23 (Pneumococcal Polysaccharide Vaccine)

RotaTeq (Rotavirus Vaccine Live, Oral, Pentavalent)

Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine)

Diabetes:

Januvia (sitagliptin)

Janumet (sitagliptin and metformin)

Infectious Diseases:

Isentress (raltegravir)

Prevymis (letermovir)

Cardiovascular:

Zetia (ezetimibe)

Vytorin (ezetimibe and simvastatin)

Other Therapeutic Areas:

Products addressing respiratory conditions, immunology, and women's health.

Animal Health:

Through its MSD Animal Health division, the company also offers a comprehensive portfolio of products for companion animals and livestock, including:

Bravecto (fluralaner)

Nobivac (various animal vaccines)

This list represents key products from their global portfolio that are marketed and sold in Singapore.